Workshop: Advancing CAR-T Cell Therapy Workflow with Novel Cell Selection and Non-Viral Delivery Methods

This session will explore how next-generation technologies—including novel cell selection and non-viral delivery platforms—can streamline CAR-T manufacturing workflows. Through a real-world proof-of-concept case study, we’ll highlight critical success factors such as workflow ease and performance data, including cell viability, purity, recovery, and gene transfer.